Bayer Aktiengesellschaft (ETR:BAYN - Get Free Report) fell 1.1% during mid-day trading on Monday . The stock traded as low as €27.64 ($32.14) and last traded at €27.67 ($32.17). 3,613,197 shares changed hands during mid-day trading, The stock had previously closed at €27.97 ($32.52).
Bayer Aktiengesellschaft Price Performance
The firm has a market cap of $27.82 billion, a PE ratio of -31.61, a P/E/G ratio of 36.39 and a beta of 0.97. The business's fifty day moving average is €25.85 and its 200-day moving average is €23.24.
Bayer Aktiengesellschaft Company Profile
(
Get Free Report)
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bayer Aktiengesellschaft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bayer Aktiengesellschaft wasn't on the list.
While Bayer Aktiengesellschaft currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
